Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Paone, G. L. Di Tanna, S. Batzella, F. Belli, S. D‘Antonio, M. G. Alma, G. Schmid, G. Puglisi, A. Vestri (Rome, Italy). A combinational approach to optimize biomarkers efficacy in identifying patients with sarcoidosis and monitoring respiratory functional worsening. Eur Respir J 2012; 40: Suppl. 56, 3678

Member's Comments

No comment yet.

Related content which might interest you: Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Novel lung function tests can improve phenotyping and differential therapy in COPD Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 Sputum induction for assessment of biomarkers in early development of new drugs for respiratory disease in a proof of concept setting Source: International Congress 2016 – Airway biomarkers Year: 2016 The relevance of respiratory muscle dysfunction and novel treatment options in COPD Source: International Congress 2017 – PG18 Targeting the locomotor and respiratory muscles in chronic obstructive pulmonary disease: novel interventional tools and rehabilitation strategies Year: 2017 Identifying patients with severe asthma that will be benefit from biological therapy Source: Virtual Congress 2020 – Rethinking asthma Year: 2020 Identifying tools to investigate outcomes following an exacerbation of COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 The role of biomarkers and effectiveness of maintenance therapy in stable severe COPD Source: International Congress 2017 – COPD management Year: 2017 Does acute and persistent metabolic dysregulation in COVID-19 point to novel biomarkers and future therapeutic strategies? Source: Eur Respir J, 59 (2) 2102417; 10.1183/13993003.02417-2021 Year: 2022 COPD: implementing biomarkers to improve prognosis Source: Virtual Congress 2021 – Clinical year in review Year: 2021 On the temporal characterisation of novel capnometric indices for personalised monitoring and treatment optimisation of COPD Source: International Congress 2019 – Insights into physiological diagnostic services Year: 2019 The results of long-term respiratory function monitoring of the patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 425s Year: 2003 A novel monitoring device in predicting asthma exacerbation in children Source: Eur Respir J 2006; 28: Suppl. 50, 251s Year: 2006 Clinical clustering of COPD patients is useful to predict future COPD exacerbations Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 Do cardiac biomarkers predict long-term outcomes from exacerbations of COPD? Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Comparison of multidimensional assessment systems with regard to risk prediction for exacerbations of COPD Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Application of biomarkers and patient characteristics to personalize asthma treatment for children Source: International Congress 2016 – Deep phenotyping to improve treatment outcomes in paediatric asthma Year: 2016 Genetic studies as a tool for identifying novel potential targets for treatment of COPD Source: Eur Respir J, 50 (5) 1702042; 10.1183/13993003.02042-2017 Year: 2017 The effectiveness of early pulmonary rehabilitation in acute exacerbation of COPD in the terms of functional and systemic markers. Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation Year: 2020 Advances in the clinical prediction rules that are used to assess patients with possible pulmonary embolism Source: International Congress 2018 – Advances in idiopathic pulmonary fibrosis treatment, tracheobronchial reconstruction using bioengineering and clinical prediction rules for diagnosing pulmonary embolism Year: 2018 Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019 Year: 2019